Clinical Trial Update: Recurrent ESBL-producing Enterobacteriaceae Bacteremia: Risk Factor, Molecular Character and Susceptibility Change

View source ↗

Summary

This clinical trial update discusses recurrent ESBL-producing Enterobacteriaceae bacteremia, focusing on risk factors, molecular characteristics, and shifts in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Bacteremia | Status: UNKNOWN